Keyphrases
Prostate Cancer
100%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Systemic Therapy
100%
Hormone-sensitive Prostate Cancer
100%
United States
50%
Cancer Mortality
50%
Clinical Trials
50%
Patient Survival
50%
Glands
50%
Metastatic Disease
50%
Treatment Efficacy
50%
Tumor Biology
50%
Radiation Therapy
50%
Surgery Therapy
50%
Cancer Causes
50%
Localized Prostate Cancer
50%
Androgen Ablation Therapy
50%
New Tumor
50%
Medicine and Dentistry
Prostate Cancer
100%
Chemotherapy
100%
Systemic Therapy
100%
Disease
50%
Malignant Neoplasm
50%
Castration Resistant Prostate Cancer
50%
Radiation Therapy
25%
Metastatic Carcinoma
25%
Clinical Trial
25%
Tumor Biology
25%
Androgen
25%
Cancer Mortality
25%
Ablation Therapy
25%
Nursing and Health Professions
Prostate Cancer
100%
Systemic Therapy
100%
Chemotherapy
100%
Disease
50%
Malignant Neoplasm
50%
Castration Resistant Prostate Cancer
50%
Neoplasm
25%
Cancer Mortality
25%
Androgen
25%
Radiotherapy
25%
Ablation Therapy
25%
Metastasis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Disease
50%
Malignant Neoplasm
50%
Castration Resistant Prostate Cancer
50%
Neoplasm
25%
Clinical Trial
25%
Metastasis
25%
Androgen
25%
Cancer Mortality
25%